Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $1079.28
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune...
4SC AG (FWB:VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today...
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune and...
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications...
4SC AG (Frankfurt, Prime Standard: VSC) and Yakult Honsha Co.; Ltd. (Tokyo: 2267) today announced the grant of an exclusive...
4SC (Frankfurt, Prime Standard: VSC), a drug discovery and development company, today announced that the first patient has been...
4SC (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications, will...
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company, today announced that the first patient has...
4SC (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.